imipramine has been researched along with Encephalopathy, Hepatic in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaefer, MS | 1 |
| Edmunds, AL | 1 |
| Markin, RS | 1 |
| Wood, RP | 1 |
| Pillen, TJ | 1 |
| Shaw, BW | 1 |
1 other study available for imipramine and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Hepatic failure associated with imipramine therapy.
Topics: Child; Hepatic Encephalopathy; Humans; Imipramine; Intracranial Pressure; Liver; Male | 1990 |